Sensus Healthcare, Inc.
SRTS
$4.19
$0.081.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -22.12% | -20.82% | -21.75% | 3.97% | 126.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.12% | -20.82% | -21.75% | 3.97% | 126.76% |
| Cost of Revenue | 15.89% | 15.62% | -0.27% | 25.84% | 88.53% |
| Gross Profit | -48.23% | -46.47% | -34.64% | -9.26% | 163.45% |
| SG&A Expenses | 20.16% | 31.07% | 54.23% | 142.17% | 2.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.72% | 27.57% | 41.33% | 62.23% | 26.77% |
| Operating Income | -271.84% | -198.03% | -191.65% | -69.05% | 178.89% |
| Income Before Tax | -235.79% | -180.33% | -179.39% | -66.30% | 212.56% |
| Income Tax Expenses | -362.25% | -224.87% | -86.70% | -74.29% | 547.20% |
| Earnings from Continuing Operations | -177.61% | -164.33% | -213.10% | -63.28% | 183.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -177.61% | -164.33% | -213.10% | -63.28% | 183.74% |
| EBIT | -271.84% | -198.03% | -191.65% | -69.05% | 178.89% |
| EBITDA | -259.63% | -191.60% | -186.57% | -67.87% | 184.36% |
| EPS Basic | -177.69% | -164.21% | -212.75% | -63.43% | 183.41% |
| Normalized Basic EPS | -235.94% | -180.24% | -179.23% | -66.46% | 209.16% |
| EPS Diluted | -185.71% | -164.21% | -214.61% | -63.43% | 177.78% |
| Normalized Diluted EPS | -236.14% | -180.43% | -179.29% | -66.64% | 209.00% |
| Average Basic Shares Outstanding | -0.01% | 0.13% | 0.29% | 0.39% | 0.31% |
| Average Diluted Shares Outstanding | -0.16% | -0.08% | 0.15% | 1.04% | 0.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |